Drug targeting to the liver with lactosylated albumins: Does the glycoprotein target the drug or is the drug targeting the glycoprotein?

Peter van der Sluijs, Hans P. Bootsma, Bart Postema, Frits Moolenaar, Dirk K. F. Meijer – 1 July 1986 – The isolated perfused rat liver preparation was employed to study hepatic disposition of the model drugcarrier conjugate fluorescein‐lactosylated albumin (F‐LnHSA) with special reference to the influence of the organic anion fluorescein on liver cell specificity of the endocytosed neoglycoprotein. Hepatic clearance of fluoresceinated neoglycoproteins was significantly faster than clearance of radioiodinated neoglycoproteins.

Nodular regenerative hyperplasia of the liver associated with the toxic oil syndrome: Report of five cases

José A. Solis‐Herruzo, José V. Vidal, Francisco Colina, Fermin Santalla, Gregorio Castellano – 1 July 1986 – Nodular regenerative hyperplasia of the liver developed in five patients who had the toxic oil syndrome caused by ingestion of adulterated cooking oil. This hepatic complication was detected from 19 to 37 months (mean‐2.5 years) after the onset of the toxic oil syndrome. Nodular regenerative hyperplasia was asymptomatic, although all patients had persistently abnormal liver function.

Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration

David Westaby, Walter Melia, John Hegarty, Alexander E. S. Gimson, Anthony J. Stellon, Roger Williams – 1 July 1986 – In a prospective, randomized controlled trial, 53 patients with variceal hemorrhage from portal hypertension, including 44 with cirrhosis, were allocated, after initial control of the bleeding, to treatment by sclerotherapy alone, or by this together with oral propranolol in a dose sufficient to reduce resting pulse rate by 25% during the period up to the time when varices were obliterated.

Intrahepatic cholangiectases and large‐duct obliteration in primary sclerosing cholangitis

Jurgen Ludwig, Robert L. Maccarty, Nicholas F. Larusso, Ruud A. F. Krom, Russell H. Wiesner – 1 July 1986 – We studied intrahepatic bile ducts of five patients with chronic ulcerative colitis and primary sclerosing cholangitis. The livers had been obtained at the time of orthotopic liver transplantation. After specimen cholangiography and perfusion fixation, sequential blocks and sections from portal tracts were studied, combining light microscopy with scanning electron microscopy. In vivo cholangiograms were studied also.

Glutathione S‐transferases: Of rats and men

R. E. Kirsch, N. M. Bass – 1 July 1986 – Rat liver glutathione S‐transferases have been purified to apparent electrophoretic homogeneity by S‐hexylglutathione‐linked Sepharose 6B affinity chromatography and CM‐cellulose column chromatography. At least 11 transferase activity peaks can be resolved including five Yb size homodimeric isozymes, two Yc size homodimeric isozymes, one Ya homodimeric isozyme, one Yα homodimeric isozyme, and two Ya‐Yc heterodimeric isozymes.

Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: Comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy

Jaime Bosch, José M. Bordas, Joaquín Rigau, Carmen Viola, Ricardo Mastai, David Kravetz, Miguel Navasa, Joan Rodés – 1 July 1986 – Measurements of variceal pressure with a noninvasive endoscopic pressure gauge and by direct variceal puncture were performed in 20 cirrhotic patients with portal hypertension in the course of the first session of therapeutic sclerotherapy following an episode of variceal bleeding.

Hepatitis B virus infection and liver disease in ethiopian immigrants to Israel

Edna Ben‐Porath, Lea Hornstein, Jerome Zeldis, Jacob Nahmias, Mignon Gruia, Batia Bilgoray, Yehudit Satinger – 1 July 1986 – We assessed infection with hepatitis B virus in 357 Ethiopians who immigrated to Israel. Hepatitis B virus infection, as measured by the presence in the serum of HBsAg, anti‐HBs, or anti‐HBc, started at an early age (35% at the age of 1 to 4 years) and reached an overall rate of 98% in individuals over 40 years old. A high rate of HBsAg antigenemia in the young age group (19% at the age of 1 to 8 years) was associated with HBeAg and serum hepatitis B virus DNA.

Subscribe to